By Nancy Lapid April 10 (Reuters) - Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to ...

New rare genetic variants are linked to ALS, expanding understanding of genetic contributors. About a quarter of ALS cases have an identifiable genetic contributor. Findings support broader use of ...

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...

The reasons why people have such varied experiences has been unclear, though new research from the 23andMe genetic testing ...

The weight you lose and the nausea you experience from GLP-1 drugs may be linked to common gene variants, but they can’t ...

Me Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies ...

The Human Genetics Research Group of the University of Tartu Faculty of Medicine has identified a gene whose defect may cause ...

A study by 23AndMe reveals genetic variants are linked to responses and side effects of GLP-1 obesity drugs. A mutation in GLP1R affects weight loss, while GIPR impacts side effects. Findings suggest ...

BUFFALO, N.Y. — A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher risk of developing heart failure, which can be fatal, ...

Genetic risk models, including PREMMplus and BOADICEA/CanRisk, refine breast cancer risk assessment by incorporating genetic status and polygenic risk scores. Challenges in classifying gene variants, ...

As researchers continue to pursue the genetic drivers behind heritable cardiac conditions, new research has revealed genetic variants that cause cardiomyopathy also increase the risk for atrial ...